Back to Explorer

Guidance for Industry: Best Practices for Convening a GRAS Panel

FinalCenter for Veterinary Medicine Human Foods Program12/20/2022

Description

This guidance document is intended to provide our recommendations on best practices for convening a “GRAS panel.” By “GRAS,” we mean “generally recognized as safe.” See section II.A for a discussion of the GRAS provision of the Federal Food, Drug, and Cosmetic Act (FD&C Act). By “GRAS panel,” we mean a panel of qualified experts who independently evaluate whether the available scientific data, information, and methods establish that a substance is safe under the conditions of its intended use in human food or animal food as part of an evaluation of whether adding that substance to food is lawful under the GRAS provision of the FD&C Act.

Scope & Applicability

Product Classes

5
human food

Substances used in human food evaluated for safety.; Substances intended for use in food for humans.

food substance

Specialized expertise applicable to the scientific considerations associated with the intended conditions of use of a food substance.

Infant formula

subject to 21 CFR parts 106 and 107

animal food

Substances used in animal food evaluated for safety.; Substances intended for use in food for animals.

food additive

Section 201(s) of the FD&C Act defines a 'food additive'

Stakeholders

8
organizer

party who assembles a GRAS panel; A proponent or third party responsible for convening a GRAS panel.; These decisions are the GRAS panel organizer's responsibility.; The person or entity that provides data to the GRAS panel and documents its deliberations.

FDA Advisory Committee Members

Individuals serving on FDA advisory committees

Qualified expert

An individual qualified by scientific training and experience to evaluate the safety of substances in food.

GRAS panel

A panel of qualified experts who independently evaluate whether scientific data establish safety.; experts who would be both qualified and available to serve on a GRAS panel; A GRAS panel report could not provide evidence that the available data and information are generally accepted if there is a severe conflict among experts.; A panel of experts convened to evaluate whether the use of a substance is safe and generally recognized as safe.

proponent

A person responsible for a conclusion that a substance may be used in food on the basis of the GRAS provision.; The party using GRAS panel information to reach a decision; party who takes responsibility for a conclusion of GRAS status; The GRAS panel report would more appropriately be a resource for the proponent to use in identifying data gaps.; The entity responsible for drawing a conclusion on whether a substance satisfies GRAS criteria.

organizers

persons who assemble a GRAS panel and provide the framework for its deliberations

Special Government Employee

Advisory committee members subject to conflict of interest requirements; advisory committee members during their service; Enabling participation of a Special Government Employee in an FDA advisory committee.

notifier

person responsible for a GRAS notice submitted to FDA; The person who submitted the GRAS notice.

Regulatory Context

Attributes

5
generally recognized as safe

The standard for substances added to food under the FD&C Act.

honoraria

Compensation provided to members of a GRAS panel.

financial interest

conflict of interest restriction for qualified individuals

Safe level of intake

Safe level of intake is in a narrow range

General Acceptance

A key aspect of the GRAS criteria supported by scientific evidence

Identified Hazards

Hazards

2
safety concerns

Ongoing scientific discussion or controversy about safety concerns

Bias

mitigate potential unwanted bias in learning or performance estimation

Related CFR Sections (7)

Related Warning Letters (10)

  • Adulterated Human Foods/Misbranded

    STNR Creations, LLC

    2025-09-30
  • Adulterated Human Foods/Misbranded

    Blue Forest Farms, LLC

    2025-09-16
  • Adulterated Human Foods/Misbranded

    TKO Distribution, LLC

    2025-08-12
  • Unapproved New Drug/Human Food/Adulterated

    Hydroxie, LLC

    2025-07-15
  • Unapproved New Drug/Misbranded

    Royal Diamond Imports, Inc.

    2025-07-15
  • CGMP/Dietary Supplement/Adulterated/Misbranded

    Thang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ

    2025-07-15
  • Adulterated Human Foods/Misbranded

    Latro Inc.

    2025-06-03
  • Unapproved New Animal Drug Products

    Holista LLC dba HolistaPet

    2025-04-29
  • Unapproved New Animal Drug Products

    Bailey’s Wellness, LLC dba Bailey’s CBD

    2025-04-29
  • Adulterated Human Foods/Unapproved New Drugs

    White Label Leaf, LLC/Flying Monkey US, LLC

    2024-07-23

See Also (8)